Brazilian journal of otorhinolaryngology
The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review.
Antonio Moffa, Eugenio de Corso, Domiziana Nardelli, Antonella Loperfido, Jacopo Galli, Peter Baptista, Manuele Casale
Published: 202610.1016/j.bjorl.2026.101768
Abstract
OBJECTIVE: This systematic review aims to evaluate the effectiveness of Tezepelumab, a monoclonal antibody targeting the thymic stromal lymphopoietin, in patients affected by chronic rhinosinusitis with nasal polyposis, both with and without comorbid…
Preview only. Read the full abstract at the source